Market Research Blog

Increasing contact lens usage, emerging new treatment options such as anti-amoebic drugs, and well-established supply chain operations are expected to fuel the growth of the corneal ulcer treatment market. Various initiatives by global as well as regional organizations, governments, etc., to eliminate avoidable blindness caused due to contact lens use, are helping to increase awareness about corneal ulcer among the general public as well as ophthalmologists.

Further, universities and non-profit organizations arranging eye check-up camps further aids in enhancing awareness about corneal ulcers.

FMI – a well-established name in the market research domain – forecasts that, the corneal ulcer treatment market will experience a major upturn in the coming years, reaching a valuation of US$ 1.3 Bn by 2029.

“Low-cost drugs being offered by generic drug manufacturers, especially in emerging countries, has substantially lowered treatment cost, and is giving tough competition to key players in the global corneal ulcer treatment market.”

Get Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6953

Key Takeaways of Corneal Ulcer Treatment Market Study

• Treatment of broad-spectrum corneal ulcers using antibiotics is expected to gain traction and contribute more than 75% of revenue share during the forecast period.
• Growing bacterial keratitis requiring antibiotics for treatment will contribute significantly to the revenue share of the segment.
• Eye drops or eye ointments dominate the market by form type, as these are relatively cheaper and do not require other interventional and oral route for drug delivery.
• By distribution channel, retail pharmacies are expected to gain more than 50% of market share during the forecast period.
• North America is dominating the global corneal ulcer treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to rising healthcare infrastructure and industrialization.

Acquisition – Key Strategy Followed by Leading Manufacturers

Leading manufacturers in the corneal ulcer treatment market are focusing on geographical expansion as well as increased product offerings through partnerships and acquisitions. In order to evaluate cost effective therapy for corneal ulcer treatment, manufacturers are evaluating new drugs via clinical trials For example, in Dec. 2019, Mallinckrodt plc enrolled the first patient in the company’s Phase 4, multi-center, multiple-dose, open-label study to assess the effects of Acthar Gel as a therapy option in patients with severe keratitis.

Want more insights?

A new study by Future Market Insights opines on the evolution of the corneal ulcer treatment market from 2014–2018, and presents demand projections for 2019–2029 on the basis of drug class (antibiotics, antifungals, antivirals, anti-amoebic drugs, corticosteroids, and NSAIDs), indication (bacterial keratitis, fungal keratitis, viral keratitis, and acanthamoeba keratitis), form (tablets, eye drops, and vials), and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), across seven prominent regions.

Speak To Analyst For Queries about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-6953

Reasons to Buy the report

• We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
• Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
• The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape

• Vascular Ulcer Treatment Market
• Corneal Edema Treatment Market
• Decubitus Ulcer Treatment Products Market

Short-term demand for Surgical Masks remains unprecedented, however, growing awareness regarding their effectiveness will lead to steady sales in the long-term, according to a latest study by Future Market Insights. According to the study, even after the COVID-19 pandemic is brought under control, a sizeable percentage of people are likely to continue wearing masks in crowded places, and cities where pollution levels are high.

Key Report Takeaways

• The global surgical masks market is forecasted to surge past valuation of US$ 4.2 Bn by 2030
• Basic surgical masks and fluid/splash resistant surgical masks are expected to collectively account for 80% of market value, each holding a share of near-equal proportions.
• The adoption of basic surgical masks is concentrated among general consumers while fluid/splash resistant surgical masks find a majority of takers among medical professionals.
• By end-use, hospitals are foreseen to channel the majority of revenue, capturing more than 70% of market value.
• Ambulatory surgical centers are anticipated to remain the second-most lucrative market, accounting for more than 1/5th of global market value.
• Europe is poised to capture the lion’s share in market value, accounting for a share little below 2/5th of market value.

“Market players are leveraging the unprecedented demand for surgical masks created by the pandemic and are focusing on increasing their brand visibility,” remarks FMI analyst.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11197

Through the years, surgical masks have remained one of the most prominent protective equipment among healthcare professionals while performing medical procedures.

Surgical masks offer protection against exposure to harmful bacteria and other organisms present in the blood and other bodily fluids that the medical professionals are likely to come in contact with during surgical procedures.

As the number of surgeries continues to increase in direct proportion with the expanding base of the geriatric population, the demand for protective surgical equipment, including surgical masks, is expected to prevail high for the years to come.

As per the statistics of The Lancet, the number of surgeries conducted across the world surged passed 313 Mn in recent years and continues to rise year-on-year, offering substantial revenue opportunities to market players.

Speak To Research Analyst For Detailed Insights: https://www.futuremarketinsights.com/ask-question/rep-gb-11197

Speak To Research Analyst For Detailed Insights: 

Likewise, high levels of air pollution in East Asian nations such as China, South Korea, and Japan have made wearing masks a common practice among the population of these regions.

Besides, the sales of masks in the aforementioned regions have historically witnessed an upsurge during the flu seasons. On these lines, the outbreak of COVID-19 is creating an unprecedented demand for surgical masks, as they become an integral part of routine during the pandemic.

COVID-19 Impact on Surgical Masks Market

The outbreak of COVID-19 has proven fruitful to the manufacturers of surgical masks, as demand for surgical masks has never been higher. As the number of infections continues to spike in large nations such as the US, India, Brazil, and Russia, with no vaccine approval in sight, people are resorting to all kinds of protective measures in their routine.

On this premise, surgical masks have emerged as the most accessible and efficient safety measure, and have become an integral part of their lives. Surgical masks are currently among the most sought out essentials and are poised to remain through the pandemic, thus catalysing the overall market growth.

Download TOC @ https://www.futuremarketinsights.com/reports/surgical-mask-market/table-of-content

Who is Winning?

Key players operating in the market are capitalizing on the demand created during the pandemic and are upscaling their production capacities to gain a competitive edge. Moreover, market players are focusing on procuring approvals for new products to distribute on a wide-scale. On these lines,

3M is committed to producing 50 Mn masks to the US medical authorities during the pandemic.

Similarly, Honeywell International has expanded its manufacturing capacity in its facility located in Smithfield, Rhode Island, to cater to the growing demand.

FMI’s report includes profiles of some of the most prominent names in the market including 3M, Honeywell International Inc., and Medline Industries, Inc., Halyard Health (Owens & Minor, Inc.), Kimberly-Clark Worldwide, Inc., Medline Industries, Inc., Moldex-Metric Inc., Kowa Company Ltd., Premium HealthCare Disposables Private Limited, Kindwell Medical BioClean (ANSELL LTD.), Dynarex Corp., and Valmy among others.

To Know More About Surgical Masks Market

A new market research report published by Future Market Insights (FMI) on the global surgical masks market offers an executive-level blueprint of the market. It offers insights into demand trends and provides analysis of opportunities over the forecast period, 2020-2030. The report examines the market through four different segments – product, end-use, and region. The report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the supply and product adoption across several end-use industries.

Buy Industry Research Report: https://www.futuremarketinsights.com/checkout/11197

The cancer supportive care products market is anticipated to reach a valuation of US$ 32 billion by 2030. The industry is expected to be marginally impacted by the ongoing crisis of the coronavirus outbreak. The critical nature of cancer treatment is a key factor that supports the production and sales of cancer supportive care products. On the other hand, potential risks of coronavirus on immunocompromised cancer patients can create challenges in the industry.

As the FMI report foresees the future of the cancer supportive care products market, the demand will expand at a notable CAGR of during the forecast period of 2020 to 2030. In terms of revenue, the concerned market is poised to attain a valuation of US$ 32 Bn by the end of 2030, Cancer supportive care products market is expected to grow at about 4% y-o-y in 2020. As per the World Cancer Research Fund International (WCRF), it has been projected that there will be more than 24 million cases of cancer by 2035 globally. These numbers do not include non-melanoma skin cancer. According to the National Cancer Institute (NIH), there were more than a million cancer cases in the U.S. itself

“Most prominent cancer treatment therapies have been known to cause a wide range of potentially serious side effects. Consequently, the role of cancer supportive care drugs is essential in reducing such side effects. So, increasing incidences of cancer has a direct impact on the growth of this market for the foreseeable future,” says the report by FMI.

Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-2550

Cancer Supportive Care Products Market – Primary Takeaways

• Erythropoietin stimulating agents are accounting for major market share, owing to superior efficacy in supporting the patient’s immunity capacities during treatment.
• Supportive care for breast cancer is rapidly gaining ground, supported by high investments by private and public bodies toward breast cancer awareness campaigns.
• North America is a major market for cancer supportive care products, aided by favorable reimbursement policies, and better healthcare infrastructure.

Cancer Supportive Care Products Market – Growth Factors

• Steadily rising incidences of cancer, coupled with higher incomes and better healthcare facilities are key driving factors.
• High investments by governments and healthcare companies towards product development support adoption.

Cancer Supportive Care Products Market – Major Constraints

• The increasing use of targeted therapy drugs for cancer reduces side effects and the requirement of supportive care products.
• Strict regulations and slow approval of cancer supportive care products holds back market growth.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-2550

The Projected Impact of Coronavirus

With the high level of contagiousness of the covid-19 virus, healthcare facilities are being forced to balance the need for cancer therapies, with the potential risk of severe complications arising from a coronavirus infection, particularly as most cancer patients are immunocompromised for the duration of the treatment. Supportive care products which can minimize clinic and hospital visits are gaining preference. As a result, telehealth options are likely to gain ground during the pandemic.

Competition Landscape

The cancer supportive care products market comprises players including but not limited to Teva Pharmaceutical Industries Ltd., Amgen Inc., Fagron, Johnson & Johnson Pvt. Ltd., Hoffmann La Roche Ltd., Baxter, Novartis AG, Heron Pharma, Bendalis Gmbh, Enlivity Corporation, and ARIAD Pharmaceuticals.

Participants in the cancer supportive care products market are largely displaying interest in setting up clinical trials, and acquiring regulatory approval for new offerings in development.

For instance, Pfizer announced the FDA approval for Bavencio – avelumab for supportive care in advanced bladder cancer. Similarly, Specialized Therapeutics Asia’s NERLYNX for early breast cancer care has received approval by the National Pharmaceutical Regulatory Agency of Malaysia. Javelin Pharmaceutical Inc. has set up a promising clinical trial for second-line immunotherapy for its bladder cancer supportive care drug.

Request Special Price for this Report to our Sales Executive@ https://www.futuremarketinsights.com/request-special-price/rep-gb-2550

More About the Study

The FMI study provides detailed insights on cancer supportive care products market. The market is broken down in terms of drug class (non-steroidal anti-inflammatory drugs, anti-infective, anti-emetic, monoclonal antibodies, erythropoietin stimulating agent, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factor), indication (lung cancer, breast cancer, prostate cancer, liver cancer, bladder cancer, leukemia, ovarian cancer, melanoma, and others), and distribution channel (Hospital pharmacy, retail pharmacy, and compounding pharmacy), across seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Explore Future Market Insights Coverage of the Healthcare, Pharmaceuticals & Medical Devices Industry

Point-of-care Cholesterol Monitoring Device Market: Find insights on the Point-of-care Cholesterol Monitoring Device Market with segment analysis, statistics, influencing factors, players and key strategies adopted by market players for a 10-year forecast period.

General Anesthesia Drugs Market: FMI’s report on the general anesthesia drugs market offers details on the market between 2019 -2029. The study covers influencers, revenue sources, market leaders, and strategies.

Electronic Medical Records (EMR) Market: Get an in-depth analysis on the electronic medical records (EMR) market with insights on growth levers, opportunities, policies, restraints, regional markets and market leaders.